GC Medical Science Corporation (KOSDAQ:142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,500.00
-110.00 (-3.05%)
At close: Oct 23, 2026

GC Medical Science Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
102,158108,413103,85294,011113,109101,675
Revenue Growth
-8.46%4.39%10.47%-16.89%11.25%-10.32%
Gross Profit
13,52915,02214,76713,95512,7461,631
Operating Income
2,3682,8872,2611,272-1,808-20,164
Net Income
-2,1623,6663,5811,797-3,581-21,202
Earnings Per Share
-98.28145.7541.0475.80-170.00-1006.40
EPS Growth
-255.16%-45.86%---

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Green Cross MS Co., Ltd.
102,888109,122104,60094,066110,820100,829
Green Cross Medis Co., Ltd.
14,99515,83313,16311,75614,88412,789
Consolidated Adjustments
-15,725-16,541-13,911-11,811-12,595-11,944
Total
102,158108,413103,85294,011113,109101,675

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
261.34372.63678.495,74410,7511,843
Total Debt
15,22417,45417,35322,58023,40136,981
Net Cash (Debt)
-14,963-17,081-16,675-16,836-12,650-35,139
Net Cash Growth
------
Net Cash Per Share
-680.22-640.31-623.49-629.11-600.13-1667.93

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
8,3577,1963,6614,24110,880-18,195
Capital Expenditures
-1,023-4,720-3,216-5,632-3,426-3,598
Free Cash Flow
7,3342,476445.24-1,3917,454-21,793
Free Cash Flow Growth
-456.00%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
13.24%13.86%14.22%14.84%11.27%1.60%
Operating Margin
2.32%2.66%2.18%1.35%-1.60%-19.83%
Pretax Margin
-2.96%1.90%3.27%1.98%-2.61%-20.76%
Profit Margin
-2.12%3.38%3.45%1.91%-3.17%-20.85%
FCF Margin
7.18%2.28%0.43%-1.48%6.59%-21.43%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-23.7521.7055.95--
Forward PE
-34.2434.2434.2434.2434.24
P/FCF Ratio
11.4435.17174.54-16.35-
PS Ratio
0.820.800.751.071.081.50